Copertina

The significant costs of prostate cancer management—An analysis from a Caribbean hospital

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Geneva Pantoja, Amanda Wibben, Visham Bhagaloo, Sara Seetaram, Satyendra Persaud
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	BJUI Compass
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
di: Eric V. Li, et al.
Pubblicazione: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
di: Herbert Lepor, et al.
Pubblicazione: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
di: Muhammad Imran, et al.
Pubblicazione: (2026)

Bibliometric analysis of focal therapy in prostate cancer research
di: Mohammed Shahait, et al.
Pubblicazione: (2024)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
di: Eric Margolis, et al.
Pubblicazione: (2025)

Emerging tools for the early detection of prostate cancer
di: Muhammad Haider, et al.
Pubblicazione: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
di: Sophia M. Abusamra, et al.
Pubblicazione: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
di: Esther H. J. Hamoen, et al.
Pubblicazione: (2025)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
di: Muhammad Haider, et al.
Pubblicazione: (2025)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
di: Agnieszka Krzyzanowska, et al.
Pubblicazione: (2024)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
di: Jennifer Ward, et al.
Pubblicazione: (2025)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
di: Jennifer Dunsmore, et al.
Pubblicazione: (2024)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
di: Ali H. Zahalka, et al.
Pubblicazione: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
di: Ailene E. Corona, et al.
Pubblicazione: (2026)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
di: Arjun Pon Avudaiappan, et al.
Pubblicazione: (2024)

A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
di: Renil S. Titus, et al.
Pubblicazione: (2025)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
di: Joshua Yi Min Tung, et al.
Pubblicazione: (2026)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
di: Abel Tesfai, et al.
Pubblicazione: (2024)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
di: Sandra Irenaeus, et al.
Pubblicazione: (2025)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
di: Nadia Rokan, et al.
Pubblicazione: (2025)

National survey of urologists' views on prostate cancer screening in the United Kingdom
di: Nikhil Mayor, et al.
Pubblicazione: (2026)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
di: Ruth Pidsley, et al.
Pubblicazione: (2024)

Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
di: Oluwafolajimi Adesanya, et al.
Pubblicazione: (2024)

A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate
di: Ansh Bhatia, et al.
Pubblicazione: (2024)

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
di: Michela Roberto, et al.
Pubblicazione: (2025)

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
di: Laurence Klotz, et al.
Pubblicazione: (2024)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
di: Sofia Mesquita, et al.
Pubblicazione: (2025)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
di: Ryan Sutherland, et al.
Pubblicazione: (2024)

Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
di: Lotte G. Zuur, et al.
Pubblicazione: (2025)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
di: Ansh Bhatia, et al.
Pubblicazione: (2024)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
di: Samantha Shekar, et al.
Pubblicazione: (2025)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
di: Marcus Sondermann, et al.
Pubblicazione: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
di: Austin Drysch, et al.
Pubblicazione: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
di: Jonathon Dawson, et al.
Pubblicazione: (2024)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
di: Alan Priester, et al.
Pubblicazione: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
di: Maxwell Louis Sandberg, et al.
Pubblicazione: (2026)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
di: See‐Tong Pang, et al.
Pubblicazione: (2025)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
di: Stephen Langley, et al.
Pubblicazione: (2024)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
di: Pierre Allainguillaume, et al.
Pubblicazione: (2026)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
di: Nicole Handa, et al.
Pubblicazione: (2025)